Remember Me     Forgot Login?   Sign up   •  Web site Help & Info

!!! DISCUSSION GROUP RULES !!!

1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!

New Article Re: Eltrombopag

  • Sandi
  • Topic Author
  • Offline
  • Sandi Forum Moderator Diagnosed in 1998, currently in remission. Diagnosed with Lupus in 2006. Last Count - 344k - 6-9-18
More
14 years 9 hours ago #24198 by Sandi
New Article Re: Eltrombopag was created by Sandi
I think this is significant information for those using or thinking about using TPO's. Thoughts?


Psaila et al show that patients with untreated ITP have platelets that are more activated by flow cytometry than control patients as evidenced by increased expression of P-selectin and activated GPIIb/IIIa. There also was increased expression of GPIb, but this may reflect the larger mean platelet size noted. While the authors did not compare this platelet reactivity with patients who were thrombocytopenic for other reasons, these findings are consistent with prior reports that there may be an increased risk of thrombosis associated with ITP, that many patients with ITP do not have significant bleeding even with severe thrombocytopenia, and that platelets in patients with ITP may be activated. Interestingly, Psaila et al found that stimulation of platelets from ITP patients with the thrombin receptor activator TRAP resulted in lower responsiveness as measured by surface levels of activated GPIIb/IIIa and P-selectin expression, suggesting that while the platelets of ITP patients are more activated in the circulation, the potential for further activation of these platelets is limited in thrombocytopenic patients with ITP."


bloodjournal.hematologylibrary.org/content/119/17/3876.full?ct
The following user(s) said Thank You: poseymint

Please Log in or Create an account to join the conversation.

More
14 years 3 hours ago #24203 by poseymint
Replied by poseymint on topic Re: New Article Re: Eltrombopag
Question: What exactly does it mean: "patients with untreated ITP have platelets that are more activated..."?

Does having platelets that are more "activated" mean that they tend to clot better?

Was there was another article that you posted about ITPers having platelets that behave differently? Or maybe it was in the newsletter. Anyway, this is good information that I'll pass on to my hemo.

Thanks Sandi for the post! Very very interesting! makes a lot of sense.

Please Log in or Create an account to join the conversation.

  • Sandi
  • Topic Author
  • Offline
  • Sandi Forum Moderator Diagnosed in 1998, currently in remission. Diagnosed with Lupus in 2006. Last Count - 344k - 6-9-18
More
13 years 11 months ago #24216 by Sandi
Replied by Sandi on topic Re: New Article Re: Eltrombopag
"When a blood vessel is damaged, the platelets become activated and secrete chemicals that cause the formation of a fibrin mesh. This mesh traps platelets and red and white blood cells, forming a clot that seals the damaged blood vessel."

www.sciencephoto.com/media/151882/enlarge
The following user(s) said Thank You: poseymint

Please Log in or Create an account to join the conversation.

You’re not alone. We have answers! Contact PDSA to connect with life altering information, resources and referrals. 440.746.9003 (877.528.3538 toll-free) or PDSA@PDSA.org.

Platelet Disorder Support Association

Platelet Disorder Support Association
8751 Brecksville Road Suite 150
Cleveland, OH 44141
440.746.9003  |  pdsa@pdsa.org
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.

IMPORTANT!

The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.